Immunotherapy of lung cancer: an update

Onkologie
Dominik RüttingerKarl-Walter Jauch

Abstract

In Germany lung cancer is the leading cause of cancer-associated death in men. Surgery, chemotherapy and radiation may enhance survival of patients suffering from lung cancer but the enhancement is typically transient and mostly absent with advanced disease; eventually more than 90% of lung cancer patients will die of disease. New approaches to the treatment of lung cancer are urgently needed. Immunotherapy may represent one new approach with low toxicity and high specificity but implementation has been a challenge because of the poor antigenic characterization of these tumors and their ability to escape immune responses. Several different immunotherapeutic treatment strategies have been developed. This review examines the current state of development and recent advances with respect to non-specific immune stimulation, cellular immunotherapy (specific and non-specific), therapeutic cancer vaccines and gene therapy for lung cancer. The focus is primarily placed on immunotherapeutic cancer treatments that are already in clinical trial or well progressed in preclinical studies. Although there seems to be a promising future for immunotherapy in lung cancer, presently there is not standard immunotherapy available for clinical routine.

References

Feb 1, 1990·The Journal of Experimental Medicine·F R Carbone, M J Bevan
Jan 1, 1987·Cancer Immunology, Immunotherapy : CII·R L KradinJ T Kurnick
Jun 27, 1974·The New England Journal of Medicine·R C BastH J Rapp
Jan 1, 1996·British Journal of Cancer·P KorkolopoulouK C Gatter
Jun 1, 1996·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·H Kimura, Y Yamaguchi
May 1, 1996·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·G MelioliL Moretta
Aug 26, 1998·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·K GotohT Mitsudomi
Dec 22, 1999·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·T YanoK Sugimachi
Apr 27, 2000·Critical Reviews in Oncology/hematology·A J Bremers, G Parmiani
Jun 29, 2002·Science·John D HoodDavid A Cheresh
Dec 19, 2002·Surgical Oncology Clinics of North America·Stephen G Swisher, Jack A Roth
Feb 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lee M KrugPhilip O Livingston
Feb 19, 2004·Journal of the National Cancer Institute·John NemunaitisKristen Hege
Feb 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Djordje AtanackovicSacha Gnjatic
Mar 10, 2004·Hematology/oncology Clinics of North America·Jack A Roth, Susan F Grammer
Aug 31, 2004·Proceedings of the National Academy of Sciences of the United States of America·Margaret LiuPatrick Squiban
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Miguel A Villalona-CaleroJon Holmlund
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lee M KrugPhilip O Livingston

❮ Previous
Next ❯

Citations

Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hua ZhongGalina V Shurin
Nov 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael G LaCelleBernard A Fox
Sep 12, 2006·Chest·Martin KolbJack Gauldie
Nov 21, 2007·Surgical Oncology Clinics of North America·Dominik RüttingerBernard A Fox
Nov 13, 2007·International Immunopharmacology·Hwan Mook KimSang-Bae Han

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Kristen Hege, David P Carbone
Critical Reviews in Oncology/hematology
P MaioneC Gridelli
Critical Reviews in Oncology/hematology
A RossiC Gridelli
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Edward A HirschowitzJohn Yannelli
© 2021 Meta ULC. All rights reserved